Adaptive Biotechnologies Executive Harlan Robins Executes $1.8 Million Stock Sale Under Pre-Approved Plan
Harlan S. Robins, Chief Scientific Officer at Adaptive Biotechnologies Corp (NASDAQ: ADPT), recently executed two separate stock sales totaling $1,847,941 under a Rule 10b5-1 trading plan established in March 2026. The transactions occurred on June 15 and 16, 2026, with Robins selling 100,000 shares at a weighted-average price of $17.37 and an addi…